A5062216640- Pharmaceutical Quality and Counterfeiting
- Mobile Health and mHealth Applications
- Digital Mental Health Interventions
- Primary Care and Health Outcomes
- Advanced Text Analysis Techniques
- Pharmaceutical studies and practices
- Clinical practice guidelines implementation
- Impact of Technology on Adolescents
- History and advancements in chemistry
- Pharmaceutical Economics and Policy
- Health Policy Implementation Science
Mental Health Commission of Canada
2023-2024
St. Michael's Hospital
2019
University of Toronto
2018
To compare the medicines included in national essential lists with World Health Organization's (WHO's) Model list of medicines, and assess extent to which countries' characteristics, such as WHO region, size health care expenditure, account for differences.We searched WHO's Essential Medicines Products Information Portal lists. We compared each both 2017 model other used linear regression determine whether differences were dependent on Region, population size, life expectancy, infant...
Background Mental health Applications (Mhealth Apps) can change how healthcare is delivered. However, very little known about the efficacy of Mhealth Apps. Currently, only minimum guidance available in Assessment and Evaluation Tools (AETs). Therefore, this project aims to understand AET developers' perspectives end users' experiences opinions on “how choose a App”. Objective The primary objectives were: (1) obtaining stakeholder's development use AETs for Apps, their weaknesses strengths,...
Mental health Applications (MH Apps) can potentially improve access to high-quality mental care. However, the recent rapid expansion of MH Apps has created growing concern regarding their safety and effectiveness, leading development AETs (Assessment Evaluation Tools) help guide users. This article provides a critical, mixed methods analysis existing for by reviewing criteria used evaluate assessing effectiveness as evaluation tools.
Background: Essential medicines lists (EMLs) are intended to include that meet the priority needs of populations and they influence medication access for more than 5 billion people. The World Health Organization (WHO) maintains a Model EML countries may adapt their own circumstances. We compared included in national EMLs with WHO EML, assessed extent which countries' characteristics, such as region, size, healthcare expenditure accounted differences.